You are here
This document guides costing practitioners on the steps to capturing end-to-end COVID-19 activity and expenses under the National Partnership Agreement (NPA). It identifies the principles to be applied, the scope of activity and costs to be funded, cost allocation methods and NPA specific cost centres for cost allocation. This document also introduces two new non-patient products and provides information on how to create and map intermediate products.
IHPA has developed a robust set of standard costs for the revised List of standard items associated with conducting clinical trials in Australia.
The Mental Health Costing Study aims to produce a robust consumer level data set that is representative of mental health services provided in Australia.
The PDF documents under this section may not be accessible. If you need assistance please contact IHPA using the enquiries.ihpa [at] ihpa.gov.au (IHPA enquiries) mailbox.